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Successful reprogramming of differentiated hu-
man somatic cells into a pluripotent state would
allow creation of patient- and disease-specific
stem cells. We previously reported generation
of induced pluripotent stem (iPS) cells, capable
of germline transmission, from mouse somatic
cells by transduction of four defined trans-
cription factors. Here, we demonstrate the
generation of iPS cells from adult human dermal
fibroblasts with the same four factors: Oct3/4,
Sox2, Klf4, and c-Myc. Human iPS cells were
similar to human embryonic stem (ES) cells in
morphology, proliferation, surface antigens,
gene expression, epigenetic status of pluripo-
tent cell-specific genes, and telomerase activ-
ity. Furthermore, these cells could differentiate
into cell types of the three germ layers in vitro
and in teratomas. These findings demonstrate
that iPS cells can be generated from adult
human fibroblasts.
INTRODUCTION
Embryonic stem (ES) cells, derived from the inner cell
mass of mammalian blastocysts, have the ability to grow
indefinitely while maintaining pluripotency (Evans and
Kaufman, 1981; Martin, 1981). These properties have led
to expectations that human ES cells might be useful to un-
derstand disease mechanisms, to screen effective and
safe drugs, and to treat patients of various diseases and
injuries, such as juvenile diabetes and spinal cord injury
(Thomson et al., 1998). Use of human embryos, however,
faces ethical controversies that hinder the applications of
human ES cells. In addition, it is difficult to generate pa-
tient- or disease-specific ES cells, which are required for
their effective application. One way to circumvent theseCissues is to induce pluripotent status in somatic cells by
direct reprogramming (Yamanaka, 2007).
We showed that induced pluripotent stem (iPS) cells
can be generated from mouse embryonic fibroblasts
(MEF) and adult mouse tail-tip fibroblasts by the retrovi-
rus-mediated transfection of four transcription factors,
namely Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi and Ya-
manaka, 2006). Mouse iPS cells are indistinguishable from
ES cells in morphology, proliferation, gene expression,
and teratoma formation. Furthermore, when transplanted
into blastocysts, mouse iPS cells can give rise to adult chi-
meras, which are competent for germline transmission
(Maherali et al., 2007; Okita et al., 2007; Wernig et al.,
2007). These results are proof of principle that pluripotent
stem cells can be generated from somatic cells by the
combination of a small number of factors.
In the current study, we sought to generate iPS cells
from adult human somatic cells by optimizing retroviral
transduction in human fibroblasts and subsequent culture
conditions. These efforts have enabled us to generate iPS
cells from adult human dermal fibroblasts and other hu-
man somatic cells, which are comparable to human ES
cells in their differentiation potential in vitro and in tera-
tomas.
RESULTS
Optimization of Retroviral Transduction
for Generating Human iPS Cells
Induction of iPS cells from mouse fibroblasts requires ret-
roviruses with high transduction efficiencies (Takahashi
and Yamanaka, 2006). We, therefore, optimized transduc-
tion methods in adult human dermal fibroblasts (HDF). We
first introduced green fluorescent protein (GFP) into adult
HDF with amphotropic retrovirus produced in PLAT-A
packaging cells. As a control, we introduced GFP to
mouse embryonic fibroblasts (MEF) with ecotropic retro-
virus produced in PLAT-E packaging cells(Morita et al.,
2000). In MEF, more than 80% of cells expressed GFP
(Figure S1). In contrast, less than 20% of HDF expressedell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc. 861
Figure 1. Induction of iPS Cells from
Adult HDF
(A) Time schedule of iPS cell generation.
(B) Morphology of HDF.
(C) Typical image of non-ES cell-like colony.
(D) Typical image of hES cell-like colony.
(E) Morphology of established iPS cell line at
passage number 6 (clone 201B7).
(F) Image of iPS cells with high magnification.
(G) Spontaneously differentiated cells in the
center part of human iPS cell colonies.
(H–N) Immunocytochemistry for SSEA-1 (H),
SSEA-3 (I), SSEA-4 (J), TRA-1-60 (K), TRA-1-
81 (L), TRA-2-49/6E (M), and Nanog (N). Nuclei
were stained with Hoechst 33342 (blue). Bars =
200 mm (B–E, G), 20 mm (F), and 100 mm (H–N).GFP with significantly lower intensity than in MEF. To
improve the transduction efficiency, we introduced the
mouse receptor for retroviruses, Slc7a1 (Verrey et al.,
2004) (also known as mCAT1), into HDF with lentivirus.
We then introduced GFP to HDF-Slc7a1 with ecotropic
retrovirus. This strategy yielded a transduction efficiency
of 60%, with a similar intensity to that in MEF.
Generation of iPS Cells from Adult HDF
The protocol for human iPS cell induction is summarized
in Figure 1A. We introduced the retroviruses containing
human Oct3/4, Sox2, Klf4, and c-Myc into HDF-Slc7a1
(Figure 1B; 8 3 105 cells per 100 mm dish). The HDF de-
rived from facial dermis of 36-year-old Caucasian female.
Six days after transduction, the cells were harvested by
trypsinization and plated onto mitomycin C-treated SNL
feeder cells (McMahon and Bradley, 1990) at 5 3 104 or
5 3 105 cells per 100 mm dish. The next day, the medium
(DMEMcontaining 10%FBS) was replacedwith amedium862 Cell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc.for primate ES cell culture supplemented with 4 ng/ml
basic fibroblast growth factor (bFGF).
Approximately two weeks later, some granulated colo-
nies appeared that were not similar to hES cells in mor-
phology (Figure 1C). Around day 25, we observed distinct
types of colonies that were flat and resembled hES cell
colonies (Figure 1D). From 5 3 104 fibroblasts, we ob-
served 10 hES cell-like colonies and 100 granulated
colonies (7/122, 8/84, 8/171, 5/73, 6/122, and 11/213 in
six independent experiments, summarized in Table S1).
At day 30, we picked hES cell-like colonies and mechan-
ically disaggregated them into small clumps without enzy-
matic digestion. When starting with 5 3 105 fibroblasts,
the dish was nearly covered with more than 300 granu-
lated colonies. We occasionally observed some hES
cell-like colonies in between the granulated cells, but it
was difficult to isolate hES cell-like colonies because of
the high density of granulated cells. The nature of the
non-hES-like cells remains to be determined.
The hES-like cells expanded on SNL feeder cells with
the primate ES cell medium containing bFGF. They
formed tightly packed and flat colonies (Figure 1E). Each
cell exhibited morphology similar to that of human ES
cells, characterized by large nuclei and scant cytoplasm
(Figure 1F). As is the case with hES cells, we occasionally
observed spontaneous differentiation in the center of the
colony (Figure 1G).
These cells also showed similarity to hES cells in feeder
dependency (Figure S2). They did not attach to gelatin-
coated tissue-culture plates. By contrast, they maintained
an undifferentiated state on Matrigel-coated plates in
MEF-conditioned primate ES cell medium, but not in non-
conditioned medium.
Since these cells were similar to hES cells in morphol-
ogy and other aspects noted above, we will refer to the se-
lected cells after transduction of HDF as human iPS cells,
as we describe the molecular and functional evidence for
this claim. Human iPS cells clones established in this
study are summarized in Table S2.
Human iPS Cells Express hES Markers
In general, except for a few cells at the edge of the colo-
nies, human iPS cells did not express stage-specific em-
bryonic antigen (SSEA)-1 (Figure 1H). In contrast, they ex-
pressed hES cell-specific surface antigens(Adewumi
et al., 2007), including SSEA-3, SSEA-4, tumor-related
antigen (TRA)-1-60, TRA-1-81 and TRA-2-49/6E (alkaline
phosphatase), and NANOG protein (Figures 1I–1N).
RT-PCR showed human iPS cells expressed many un-
differentiated ES cell-marker genes (Adewumi et al.,
2007), such asOCT3/4,SOX2,NANOG, growth and differ-
entiation factor 3 (GDF3), reduced expression 1 (REX1),
fibroblast growth factor 4 (FGF4), embryonic cell-specific
gene 1 (ESG1), developmental pluripotency-associated 2
(DPPA2), DPPA4, and telomerase reverse transcriptase
(hTERT) at levels equivalent to or higher than those in
the hES cell line H9 and the human embryonic carcinoma
cell line, NTERA-2 (Figure 2A). By western blotting, pro-
teins levels of OCT3/4, SOX2, NANOG, SALL4, E-CAD-
HERIN, and hTERT were similar in human iPS cells and
hES cells (Figure 2B). Although the expression levels of
Klf4 and c-Myc increased more than 5-fold in HDF after
the retroviral transduction (not shown), their expression
levels in human iPS cells were comparable to those in
HDF (Figures 2A and 2B), indicating retroviral silencing.
RT-PCR using primers specific for retroviral transcripts
confirmed efficient silencing of all the four retroviruses
(Figure 2C). DNA microarray analyses showed that the
global gene-expression patterns are similar, but not iden-
tical, between human iPS cells and hES cells (Figure 2D).
Among 32,266 genes analyzed, 5,107 genes showed
more than 5-fold difference in expression between HDF
and human iPS cells (Tables S3 and S4), whereas 6083
genes between HDF and hES cells showed >5-fold differ-
ence in expression (Tables S5 and S6). In contrast, a
smaller number of genes (1,267 genes) showed >5-foldCdifference between human iPS cells and hES cells (Tables
S7 and S8).
Promoters of ES Cell-Specific Genes Are Active
in Human iPS Cells
Bisulfite genomic sequencing analyses evaluating the
methylation statuses of cytosine guanine dinucleotides
(CpG) in the promoter regions of pluripotent-associated
genes, such as OCT3/4, REX1, and NANOG, revealed
that they were highly unmethylated, whereas the CpG
dinucleotides of the regions were highly methylated in pa-
rental HDFs (Figure 3A). These findings indicate that these
promoters are active in human iPS cells.
Luciferase reporter assays also showed that human
OCT3/4 and REX1 promoters had high levels of transcrip-
tional activity in human iPS cells and EC cells (NTERA-2)
but not in HDF. The promoter activities of ubiquitously ex-
pressed genes, such as human RNA polymerase II (PolII),
showed similar activities in both human iPS cells and HDF
(Figure 3B).
We also performed chromatin immunoprecipitation to
analyze the histone modification status in human iPS cells
(Figure 3C). We found that histone H3 lysine 4 was meth-
ylated whereas H3 lysine 27 was demethylated in the
promoter regions of Oct3/4, Sox2, and Nanog in human
iPS cells. We also found that human iPS cells showed
the bivalent patterns of development-associated genes,
such as Gata6, Msx2, Pax6, and Hand1. These histone
modification statuses are characteristic of hES cells (Pan
et al., 2007).
High Telomerase Activity and Exponential Growth
of Human iPS Cells
As predicted from the high expression levels of hTERT,
human iPS cells showed high telomerase activity (Fig-
ure 4A). They proliferated exponentially for as least 4
months (Figure 4B). The calculated population doubling
time of human iPS cells were 46.9 ± 12.4 (clone 201B2),
47.8 ± 6.6 (201B6) and 43.2 ± 11.5 (201B7) hours. These
times are equivalent to the reported doubling time of
hES cells (Cowan et al., 2004).
Embryoid Body-Mediated Differentiation
of Human iPS Cells
To determine the differentiation ability of human iPS cells
in vitro, we used floating cultivation to form embryoid bod-
ies (EBs) (Itskovitz-Eldor et al., 2000). After 8 days in sus-
pension culture, iPS cells formed ball-shaped structures
(Figure 5A). We transferred these embryoid body-like
structures to gelatin-coated plates and continued cultiva-
tion for another 8 days. Attached cells showed various
types of morphologies, such as those resembling neuro-
nal cells, cobblestone-like cells, and epithelial cells (Fig-
ures 5B–5E). Immunocytochemistry detected cells posi-
tive for bIII-tubulin (a marker of ectoderm), glial fibrillary
acidic protein (GFAP, ectoderm), a-smooth muscle actin
(a-SMA, mesoderm), desmin (mesoderm), a-fetoprotein
(AFP, endoderm), and vimentin (mesoderm and parietalell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc. 863
Figure 2. Expression of hES Cell-Marker Genes in Human iPS Cells
(A) RT-PCR analysis of ES cell-marker genes. Primers used for Oct3/4, Sox2, Klf4, and c-Myc specifically detect the transcripts from the endogenous
genes, but not from the retroviral transgenes.
(B) Western blot analysis of ES cell-marker genes.
(C) Quantitative PCR for expression of retroviral transgenes in human iPS cells, HDF, and HDF 6 days after the transduction with the four retroviruses
(HDF/4f-6d). Shown are the averages and standard deviations of three independent experiments. The value of HDF/4f-6d was set to 1 in each ex-
periment.
(D) The global gene-expression patterns were compared between human iPS cells (clone 201B7) and HDF, and between human iPS cells and hES
cells (H9) with oligonucleotide DNA microarrays. Arrows indicate the expression levels of Nanog, endogenous Oct3/4 (the probe derived from the 30
untranslated region, which does not detect the retroviral transcripts), and endogenous Sox2. The red lines indicate the diagonal and 5-fold changes
between the two samples.endoderm) (Figures 5F–5K). RT-PCR confirmed that these
differentiated cells expressed forkhead box A2 (FOXA2,
a marker of endoderm), AFP (endoderm), cytokeratin
8 and 18 (endoderm), SRY-box containing gene 17
(SOX17, endoderm), BRACHYURY (mesoderm), Msh ho-
meobox 1 (MSX1, mesoderm), microtubule-associated
protein 2 (MAP2, ectoderm), and paired box 6 (PAX6, ec-
toderm) (Figure 5L). In contrast, expression of OCT3/4,
SOX2, and NANOG was markedly decreased. These
data demonstrated that iPS cells could differentiate into
three germ layers in vitro.864 Cell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc.Directed Differentiation of Human iPS Cells
into Neural Cells
We next examined whether lineage-directed differentia-
tion of human iPS cells could be induced by reported
methods for hES cells. We seeded human iPS cells on
PA6 feeder layer and maintained them under differentia-
tion conditions for 2 weeks (Kawasaki et al., 2000). Cells
spread drastically, and some neuronal structureswere ob-
served (Figure 6A). Immunocytochemistry detected cells
positive for tyrosine hydroxylase and bIII tubulin in the
culture (Figure 6B). PCR analysis revealed expression of
Figure 3. Analyses Promoter Regions of Development-Associated Genes in Human iPS Cells
(A) Bisulfite genomic sequencing of the promoter regions of OCT3/4, REX1, and NANOG. Open and closed circles indicate unmethylated and meth-
ylated CpGs.
(B) Luciferase assays. The luciferase reporter construct driven by indicated promoters were introduced into human iPS cells or HDF by lipofection.
The graphs show the average of the results from four assays. Bars indicate standard deviation.
(C) Chromatin Immunoprecipitation of histone H3 lysine 4 and lysine 27 methylation.dopaminergic neuron markers, such as aromatic-L-amino
acid decarboxylase (AADC), member 3 (DAT), choline
acetyltransferase (ChAT), and LIM homeobox transcrip-
tion factor 1 beta (LMX1B), as well as another neuron
marker, MAP2 (Figure 6C). In contrast, GFAP expression
was not induced with this system. On the other hand,
the expression of OCT3/4 and NANOG decreased mark-
edly, whereas Sox2 decreased only slightly (Figure 6C).
These data demonstrated that iPS cells could differentiate
into neuronal cells, including dopaminergic neurons, by
coculture with PA6 cells.CDirected Differentiation of Human iPS Cells
into Cardiac Cells
We next examined directed cardiac differentiation of hu-
man iPS cells with the recently reported protocol, which
utilizes activin A and bone morphogenetic protein (BMP)
4 (Laflamme et al., 2007). Twelve days after the induction
of differentiation, clumps of cells started beating (Fig-
ure 6D andMovie S1). RT-PCR showed that these cells ex-
pressed cardiomyocyte markers, such as troponin T type 2
cardiac (TnTc); myocyte enhancer factor 2C (MEF2C); myo-
sin, light polypeptide 7, regulatory (MYL2A); myosin,ell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc. 865
Figure 4. High Levels of Telomerase
Activity and Exponential Proliferation of
Human iPS Cells
(A) Detection of telomerase activities by the
TRAP method. Heat-inactivated (+) samples
were used as negative controls. IC, internal
control.
(B) Growth curve of iPS cells. Shown are aver-
ages and standard deviations in quadruplicate.heavy polypeptide 7, cardiac muscle, beta (MYHCB); and
NK2 transcription factor-related, locus 5 (NKX2.5) (Fig-
ure 6E). In contrast, the expression of Oct3/4, Sox2, and
Nanog markedly decreased. Thus, human iPS cells can
differentiate into cardiac myocytes in vitro.866 Cell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc.Teratoma Formation from Human iPS Cells
To test pluripotency in vivo, we transplanted human iPS
cells (clone 201B7) subcutaneously into dorsal flanks of
immunodeficient (SCID) mice. Nine weeks after injection,
we observed tumor formation. Histological examinationFigure 5. Embryoid Body-Mediated Dif-
ferentiation of Human iPS Cells
(A) Floating culture of iPS cells at day 8.
(B–E) Images of differentiated cells at day 16
(B), neuron-like cells (C), epithelial cells (D),
and cobblestone-like cells (E).
(F–K) Immunocytochemistry of a-fetoprotein
(F), vimentin (G), a-smooth muscle actin (H),
desmin (I), bIII-tubulin (J), and GFAP (K). Bars =
200 mm (A and B) and 100 mm (C–K). Nuclei
were stained with Hoechst 33342 (blue).
(L) RT-PCR analyses of various differentiation
markers for the three germ layers.
Figure 6. DirectedDifferentiations ofHu-
man iPS Cells
(A) Phase-contrast image of differentiated iPS
cells after 18 days cultivation on PA6.
(B) Immunocytochemistry of the cells shown in
(A) with bIII-tubulin (red) and tyrosine hydroxy-
lase (green) antibodies. Nuclei were stained
with Hoechst 33342 (blue).
(C) RT-PCR analyses of dopaminergic neuron
markers.
(D) Phase-contrast image of iPS cells differ-
entiated into cardiomyocytes.
(E) RT-PCR analyses of cardiomyocyte
markers. Bars = 200 mm (A and D) and
100 mm (B).showed that the tumor contained various tissues (Fig-
ure 7), including gut-like epithelial tissues (endoderm), stri-
ated muscle (mesoderm), cartilage (mesoderm), neural
tissues (ectoderm), and keratin-containing epidermal
tissues (ectoderm).CHuman iPS Cells Are Derived from HDF,
not Cross contamination
PCR of genomic DNA of human iPS cells showed that all
clones have integration of all the four retroviruses (Fig-
ure S3A). Southern blot analysis with a c-Myc cDNA probeFigure 7. Teratoma Derived from Human
iPS Cells
Hematoxylin and eosin staining of teratoma
derived from iPS cells (clone 201B7). Cells
were transplanted subcutaneously into four
parts of a SCID mouse. A tumor developed
from one injection site.ell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc. 867
revealed that each clone had a unique pattern of retroviral
integration sites (Figure S3B). In addition, the patterns of
16 short tandem repeats were completely matched be-
tween human iPS clones and parental HDF (Table S9).
These patterns differed from any established hES cell lines
reported on National Institutes of Health website (http://
stemcells.nih.gov/research/nihresearch/scunit/genotyping.
htm). In addition, chromosomal G-band analyses showed
that human iPS cells had a normal karyotype of 46XX
(not shown). Thus, human iPS clones were derived from
HDF and were not a result of cross-contamination.
Whether generation of human iPS cells depends on minor
genetic or epigenetic modification awaits further investi-
gation.
Generation of iPS Cells from Other Human
Somatic Cells
In addition to HDF, we used primary human fibroblast-like
synoviocytes (HFLS) from synovial tissue of 69-year-old
Caucasian male and BJ cells, a cell line established from
neonate fibroblasts (Table S1 and S2). From HFLS (5 3
104 cells per 100 mm dish), we obtained more than 600
hundred granulated colonies and 17 hES cell-like colonies
(Table S1). We picked six colonies, of which only two were
expandable as iPS cells (Figure S4). Dishes seeded with
5 3 105 HFLS were covered with granulated cells, and
no hES cell-like colonies were distinguishable. In contrast,
we obtained 7 to 8 and 100 hES cell-like colonies from
5 3 104 and 5 3 105 BJ cells, respectively, with only
a few granulated colonies (Table S1). We picked six hES
cell-like colonies and generated iPS cells from five colo-
nies (Figure S4). Human iPS cells derived from HFLS
and BJ expressed hES cell-marker genes at levels similar
to or higher than those in hES cells (Figure S5). They differ-
entiated into all three germ layers through EBs (Figure S6).
STR analyses confirmed that iPS-HFLS cells and iPS-BJ
cells were derived from HFLS and BJ fibroblasts, respec-
tively (Tables S10 and S11).
DISCUSSION
In this study, we showed that iPS cells can be generated
from adult HDF and other somatic cells by retroviral trans-
duction of the same four transcription factors with mouse
iPS cells, namely Oct3/4, Sox2, Klf4, and c-Myc. The
established human iPS cells are similar to hES cells in
many aspects, including morphology, proliferation, feeder
dependence, surface markers, gene expression, pro-
moter activities, telomerase activities, in vitro differentia-
tion, and teratoma formation. The four retroviruses are
strongly silenced in human iPS cells, indicating that these
cells are efficiently reprogrammed and do not depend on
continuous expression of the transgenes for self renewal.
hES cells are different frommouse counterparts inmany
respects (Rao, 2004). hES cell colonies are flatter and do
not override each other. hES cells depend on bFGF for
self renewal (Amit et al., 2000), whereas mouse ES cells
depend on the LIF/Stat3 pathway (Matsuda et al., 1999;868 Cell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc.Niwa et al., 1998). BMP induces differentiation in hES cells
(Xu et al., 2005) but is involved in self renewal of mouse ES
cells (Ying et al., 2003). Despite these differences, our data
show that the same four transcription factors induce iPS
cells in both human andmouse. The four factors, however,
could not induce human iPS cells when fibroblasts were
kept under the culture condition for mouse ES cells after
retroviral transduction (data not shown). These data sug-
gest that the fundamental transcriptional network govern-
ing pluripotency is common in human and mice, but ex-
trinsic factors and signals maintaining pluripotency are
unique for each species.
Deciphering of themechanism by which the four factors
induce pluripotency in somatic cells remains elusive. The
function of Oct3/4 and Sox2 as core transcription factors
to determine pluripotency is well documented (Boyer
et al., 2005; Loh et al., 2006; Wang et al., 2006). They
synergistically upregulate ‘‘stemness’’ genes, while sup-
pressing differentiation-associated genes in both mouse
and human ES cells. However, they cannot bind their tar-
gets genes in differentiated cells because of other inhibi-
tory mechanisms, including DNA methylation and histone
modifications. We speculate that c-Myc and Klf4 modifies
chromatin structure so that Oct3/4 and Sox2 can bind to
their targets (Yamanaka, 2007). Notably, Klf4 interacts
with p300 histone acetyltransferase and regulates gene
transcription by modulating histone acetylation (Evans
et al., 2007).
The negative role of c-Myc in the self renewal of hES
cells was recently reported (Sumi et al., 2007). They
showed that forced expression of c-Myc induced differ-
entiation and apoptosis of human ES cells. This is great
contrast to the positive role of c-Myc in mouse ES cells
(Cartwright et al., 2005). During iPS cell generation, trans-
genes derived from retroviruses are silenced when the
transduced fibroblasts acquire ES-like state. The role of
c-Myc in establishing iPS cells may be as a booster of
reprogramming rather than a controller of maintenance
of pluripotency.
We found that each iPS clone contained three to six ret-
roviral integrations for each factor. Thus, each clone had
more than 20 retroviral integration sites in total, which
may increase the risk of tumorigenesis. In the case of
mouse iPS cells, 20% of mice derived from iPS cells de-
veloped tumors, which were attributable, at least in part,
to reactivation of the c-Myc retrovirus (Okita et al.,
2007). This issue must be overcome to use iPS cells in hu-
man therapies. We have recently found that iPS cells can
be generated without Myc retroviruses, albeit with lower
efficiency (M. Nakagawa, M. Koyanagi, and S.Y., unpub-
lished data). Nonretroviral methods to introduce the
remaining three factors, such as adenoviruses or cell-
permeable recombinant proteins, should be examined in
future studies. Alternatively, one might be able to identify
small molecules that can induce iPS cells, without gene
transfer.
As is the case with mouse iPS cells, only a small portion
of human fibroblasts that had been transduced with the
four retroviruses acquired iPS cell identity. We obtained
10 iPS cells colonies from 5 3 104 transduced HDF.
From a practical point of view, this efficiency is sufficiently
high, since multiple iPS cell clones can be obtained from
a single experiment. From a scientific point of view, how-
ever, the low efficiency raises several possibilities. First,
the origin of iPS cells may be undifferentiated stem or
progenitor cells coexisting in fibroblast culture. Another
possibility is that retroviral integration into some specific
loci may be required for iPS cell induction. Finally, minor
genetic alterations, which could not be detected by karyo-
type analyses, or epigenetic alterations are required for
iPS cell induction. These issues need to be elucidated in
future studies.
Our study has opened an avenue to generate patient-
and disease-specific pluripotent stem cells. Even with
the presence of retroviral integration, human iPS cells
are useful for understanding disease mechanisms, drug
screening, and toxicology. For example, hepatocytes de-
rived from iPS cells with various genetic and disease
backgrounds can be utilized in predicting liver toxicity of
drug candidates. Once the safety issue is overcome, hu-
man iPS cells should also be applicable in regenerative
medicine. Human iPS cells, however, are not identical to
hES cells: DNA microarray analyses detected differences
between the two pluripotent stem cell lines. Further stud-
ies are essential to determine whether human iPS cells
can replace hES in medical applications.
EXPERIMENTAL PROCEDURES
Cell Culture
HDF from facial dermis of 36-year-old Caucasian female and HFLS
from synovial tissue of 69-year-old Caucasian male were purchased
from Cell Applications, Inc. When received, the population doubling
was less than 16 in HDF and 5 in HFLS. We used these cells for the
induction of iPS cells within six and four passages after the receipt.
BJ fibroblasts from neonatal foreskin and NTERA-2 clone D1 human
embryonic carcinoma cells were obtained fromAmerican Type Culture
Collection. Human fibroblasts, NTERA-2, PLAT-E, and PLAT-A cells
were maintained in Dulbecco’s modified eagle medium (DMEM, Naca-
lai Tesque, Japan) containing 10% fetal bovine serum (FBS, Japan
Serum) and 0.5% penicillin and streptomycin (Invitrogen). 293FT cells
were maintained in DMEM containing 10% FBS, 2 mM L-glutamine
(Invitrogen), 1 3 104 M nonessential amino acids (Invitrogen), 1 mM
sodium pyruvate (Sigma) and 0.5% penicillin and streptomycin. PA6
stroma cells (RIKEN Bioresource Center, Japan) were maintained in
a-MEM containing 10% FBS and 0.5% penicillin and streptomycin.
iPS cells were generated and maintained in Primate ES medium
(ReproCELL, Japan) supplemented with 4 ng/ml recombinant human
basic fibroblast growth factor (bFGF, WAKO, Japan). For passaging,
human iPS cells were washed once with PBS and then incubated
with DMEM/F12 containing 1 mg/ml collagenase IV (Invitrogen) at
37C. When colonies at the edge of the dish started dissociating
from the bottom, DMEF/F12/collangenase was removed and washed
with Primate ES cell medium. Cells were scraped and collected into
15 ml conical tube. An appropriate volume of the medium was added,
and the contents were transferred to a new dish on SNL feeder cells.
The split ratio was routinely 1:3. For feeder-free culture of iPS cells,
the plate was coated with 0.3 mg/ml Matrigel (growth-factor reduced,
BD Biosciences) at 4C overnight. The plate was warmed to room tem-
perature before use. Unbound Matrigel was aspirated off and washedCout with DMEM/F12. iPS cells were seeded onMatrigel-coated plate in
MEF-conditioned or nonconditioned primate ES cell medium, both
supplemented with 4 ng/ml bFGF. The medium was changed daily.
For preparation of MEF-conditioned medium, MEFs derived from
embryonic day 13.5 embryo pool of ICR mice were plated at 1 3 106
cells per 100 mm dish and incubated overnight. Next day, the cells
were washed once with PBS and cultured in 10 ml of primate ES cell
medium. After 24 hr incubation, the supernatant of MEF culture was
collected, filtered through a 0.22 mm pore-size filter, and stored at
20C until use.
Plasmid Construction
The open reading frame of human OCT3/4 was amplified by RT-PCR
and cloned into pCR2.1-TOPO. An EcoRI fragment of pCR2.
1-hOCT3/4 was introduced into the EcoRI site of pMXs retroviral vec-
tor. To discriminate each experiment, we introduced a 20 bp random
sequence, which we designated N20 barcode, into the NotI/SalI site
of Oct3/4 expression vector. We used a unique barcode sequence in
each experiment to avoid interexperimental contamination. The open
reading frames of human SOX2, KLF4, and c-MYCwere also amplified
by RT-PCR and subcloned into pENTR-D-TOPO (Invitrogen). All of the
genes subcloned into pENTR-D-TOPO were transferred to pMXs by
using the Gateway cloning system (Invitrogen), according to the man-
ufacturer’s instructions. Mouse Slc7a1ORF was also amplified, subcl-
oned into pENTR-D-TOPO, and transferred to pLenti6/UbC/V5-DEST
(Invitrogen) by the Gateway system. The regulatory regions of the
human OCT3/4 gene and the REX1 gene were amplified by PCR
and subcloned into pCRXL-TOPO (Invitrogen). For phOCT4-Luc and
phREX1-Luc, the fragments were removed by KpnI/BglII digestion
from pCRXL vector and subcloned into the KpnI/BglII site of pGV-
BM2. For pPolII-Luc, an AatII (blunted)/NheI fragment of pQBI-polII
was inserted into the KpnI (blunted)/NheI site of pGV-BM2. All of the
fragments were verified by sequencing. Primer sequences are shown
in Table S12.
Lentivirus Production and Infection
293FT cells (Invitrogen) were plated at 6 3 106 cells per 100 mm dish
and incubated overnight. Cells were transfected with 3 mg of pLenti6/
UbC-Slc7a1 along with 9 mg of Virapower packaging mix by Lipofect-
amine 2000 (Invitrogen), according to the manufacturer’s instructions.
Forty-eight hours after transfection, the supernatant of transfectant
was collected and filtered through a 0.45 mm pore-size cellulose ace-
tate filter (Whatman). Human fibroblasts were seeded at 8 3 105 cells
per 100mmdish 1 day before transduction. Themediumwas replaced
with virus-containing supernatant supplemented with 4 mg/ml poly-
brene (Nacalai Tesque), and incubated for 24 hr.
Retroviral Infection and iPS Cell Generation
PLAT-E packaging cells were plated at 8 3 106 cells per 100 mm dish
and incubated overnight. Next day, the cells were transfected with
pMXs vectors with Fugene 6 transfection reagent (Roche). Twenty-
four hours after transfection, the medium was collected as the first
virus-containing supernatant and replaced with a new medium, which
was collected after twenty-four hours as the second virus-containing
supernatant. Human fibroblasts expressing mouse Slc7a1 gene were
seeded at 8 3 105 cells per 100 mm dish 1 day before transduction.
The virus-containing supernatants were filtered through a 0.45 mm
pore-size filter and supplemented with 4 mg/ml polybrene. Equal
amounts of supernatants containing each of the four retroviruses
weremixed, transferred to the fibroblast dish, and incubated overnight.
Twenty-four hours after transduction, the virus-containingmediumwas
replaced with the second supernatant. Six days after transduction, fi-
broblasts were harvested by trypsinization and replated at 53 104 cells
per 100mmdish on an SNL feeder layer. Next day, themediumwas re-
placedwith Primate ES cell medium supplemented with 4 ng/ml bFGF.
The medium was changed every other day. Thirty days after transduc-
tion, colonies were picked up and transferred into 0.2 ml of Primate ESell 131, 861–872, November 30, 2007 ª2007 Elsevier Inc. 869
cell medium. The colonies were mechanically dissociated to small
clamps by pipeting up and down. The cell suspension was transferred
on SNL feeder in 24-well plates. We defined this stage as passage 1.
RNA Isolation and Reverse Transcription
Total RNA was purified with Trizol reagent (Invitrogen) and treated with
Turbo DNA-free kit (Ambion) to remove genomic DNA contamination.
One microgram of total RNA was used for reverse transcription reac-
tion with ReverTraAce-a (Toyobo, Japan) and dT20 primer, according
to the manufacturer’s instructions. PCR was performed with ExTaq
(Takara, Japan). Quantitative PCR was performed with Platinum
SYBR Green qPCR Supermix UDG (Invitrogen) and analyzed with
the 7300 real-time PCR system (Applied Biosystems). Primer se-
quences are shown in Table S12.
Alkaline Phosphatase Staining and Immunocytochemistry
Alkaline phosphatase staining was performed using the Leukocyte Al-
kaline Phosphatase kit (Sigma). For immunocytochemistry, cells were
fixed with PBS containing 4% paraformaldehyde for 10 min at room
temperature. After washing with PBS, the cells were treated with
PBS containing 5% normal goat or donkey serum (Chemicon), 1%
bovine serum albumin (BSA, Nacalai tesque), and 0.1% Triton X-100
for 45 min at room temperature. Primary antibodies included SSEA1
(1:100, Developmental Studies Hybridoma Bank), SSEA3 (1:10, a
kind gift from Dr. Peter W. Andrews), SSEA4 (1:100, Developmental
Studies Hybridoma Bank), TRA-2-49/6E (1:20, Developmental Studies
Hybridoma Bank), TRA-1-60 (1:50, a kind gift from Dr. Peter W.
Andrews), TRA-1-81 (1:50, a kind gift from Dr. Peter W. Andrews),
Nanog (1:20, AF1997, R&D Systems), bIII-tubulin (1:100, CB412,
Chemicon), glial fibrillary acidic protein (1:500, Z0334, DAKO),
a-smooth muscle actin (pre-diluted, N1584, DAKO), desmin (1:100,
RB-9014, Lab Vision), vimentin (1:100, SC-6260, Santa Cruz), a-feto-
protein (1:100, MAB1368, R&D Systems), tyrosine hydroxylase
(1:100, AB152, Chemicon). Secondary antibodies used were cyanine
3 (Cy3) -conjugated goat anti-rat IgM (1:500, Jackson Immunore-
search), Alexa546-conjugated goat anti-mouse IgM (1:500, Invitro-
gen), Alexa488-conjugated goat anti-rabbit IgG (1:500, Invitrogen),
Alexa488-conjugated donkey anti-goat IgG (1:500, Invitrogen), Cy3-
conjugated goat anti-mouse IgG (1:500, Chemicon), and Alexa488-
conjugated goat anti-mouse IgG (1:500, Invitrogen). Nucleuses were
stained with 1 mg/ml Hoechst 33342 (Invitrogen).
In Vitro Differentiation
For EB formation, human iPS cells were harvested by treating with
collagenase IV. The clumps of the cells were transferred to poly
(2-hydroxyrthyl methacrylate)-coated dish in DMEM/F12 containing
20% knockout serum replacement (KSR, Invitrogen), 2 mM L-gluta-
mine, 13 104 M nonessential amino acids, 13 104 M 2-mercaptoe-
thanol (Invitrogen), and 0.5% penicillin and streptomycin. The medium
was changed every other day. After 8 days as a floating culture, EBs
were transferred to gelatin-coated plate and cultured in the same
medium for another 8 days. Coculture with PA6 was used for differ-
entiation into dopaminergic neurons. PA6 cells were plated on gela-
tin-coated 6-well plates and incubated for 4 days to reach confluence.
Small clumps of iPS cells were plated on PA6-feeder layer in Glasgow
minimum essential medium (Invitrogen) containing 10% KSR (Invitro-
gen), 1 3 104 M nonessential amino acids, 1 3 104 M 2-mercapto-
ethanol (Invitrogen), and 0.5% penicillin and streptomycin. For cardio-
myocyte differentiation, iPS cells were maintained on Matrigel-coated
plate in MEF-CM supplemented with 4 ng/ml bFGF for 6 days. The
medium was then replaced with RPMI1640 (Invitrogen) plus B27
supplement (Invitrogen) medium (RPMI/B27), supplemented with
100 ng/ml human recombinant activin A (R & D Systems) for 24 hr,
followed by 10 ng/ml human recombinant bonemorphologenic protein
4 (BMP4, R&D Systems) for 4 days. After cytokine stimulation, the cells
were maintained in RPMI/B27 without any cytokines. The mediumwas
changed every other day.870 Cell 131, 861–872, November 30, 2007 ª2007 Elsevier IncBisulfite Sequencing
Genomic DNA (1 mg) was treatedwith CpGenome DNAmodification kit
(Chemicon), according to the manufacturer’s recommendations.
Treated DNA was purified with QIAquick column (QIAGEN). The
promoter regions of the human Oct3/4, Nanog, and Rex1 genes
were amplified by PCR. The PCR products were subcloned into
pCR2.1-TOPO. Ten clones of each sample were verified by sequenc-
ing with the M13 universal primer. Primer sequences used for PCR
amplification were provided in Table S12.
Luciferase Assay
Each reporter plasmid (1 mg) containing the firefly luciferase gene was
introduced into human iPS cells or HDF with 50 ng of pRL-TK (Prom-
ega). Forty-eight hours after transfection, the cells were lysed with
1X passive lysis buffer (Promega) and incubated for 15 min at room
temperature. Luciferase activities were measured with a Dual-Lucifer-
ase reporter assay system (Promega) and Centro LB 960 detection
system (BERTHOLD), according to the manufacturer’s protocol.
Teratoma Formation
The cells were harvested by collagenase IV treatment, collected into
tubes, and centrifuged, and the pellets were suspended in DMEM/
F12. One quarter of the cells from a confluent 100 mm dish was in-
jected subcutaneously to dorsal flank of a SCIDmouse (CREA, Japan).
Nine weeks after injection, tumors were dissected, weighted, and fixed
with PBS containing 4%paraformaldehyde. Paraffin-embedded tissue
was sliced and stained with hematoxylin and eosin.
Western Blotting
The cells at semiconfluent state were lysed with RIPA buffer (50 mM
Tris-HCl, pH 8.0, 150 mMNaCl, 1%Nonidet P-40 (NP-40), 1% sodium
deoxycholate, and 0.1% SDS), supplemented with protease inhibitor
cocktail (Roche). The cell lysate of MEL-1 hES cell line was purchased
from Abcam. Cell lysates (20 mg) were separated by electrophoresis on
8%or 12%SDS-polyacrylamide gel and transferred to a polyvinylidine
difluoride membrane (Millipore). The blot was blocked with TBST
(20 mM Tris-HCl, pH 7.6, 136 mMNaCl, and 0.1% Tween-20) contain-
ing 1% skim milk and then incubated with primary antibody solution at
4C overnight. After washing with TBST, the membrane was incubated
with horseradish peroxidase (HRP)-conjugated secondary antibody
for 1 hr at room temperature. Signals were detected with Immobilon
Western chemiluminescent HRP substrate (Millipore) and LAS3000
imaging system (FUJIFILM, Japan). Antibodies used for western blot-
ting were anti-Oct3/4 (1:600, SC-5279, Santa Cruz), anti-Sox2 (1:2000,
AB5603, Chemicon), anti-Nanog (1:200, R&D Systems), anti-Klf4
(1:200, SC-20691, Santa Cruz), anti-c-Myc (1:200, SC-764, Santa
Cruz), anti-E-cadherin (1:1000, 610182, BD Biosciences), anti-Dppa4
(1:500, ab31648, Abcam), anti-FoxD3 (1:200, AB5687, Chemicon),
anti-telomerase (1:1000, ab23699, Abcam), anti-Sall4 (1:400, ab29112,
Abcam), anti-LIN-28 (1:500, AF3757, R&D systems), anti-b-actin
(1:5000, A5441, Sigma), anti-mouse IgG-HRP (1:3000, #7076, Cell Sig-
naling), anti-rabbit IgG-HRP (1:2000, #7074, Cell Signaling), and anti-
goat IgG-HRP (1:3000, SC-2056, Santa Cruz).
Southern Blotting
Genomic DNA (5 mg) was digested with BglII, EcoRI, and NcoI over-
night. Digested DNA fragments were separated on 0.8% agarose gel
and transferred to a nylon membrane (Amersham). The membrane
was incubated with digoxigenin (DIG)-labeled DNA probe in DIG
Easy Hyb buffer (Roche) at 42C overnight with constant agitation.
After washing, alkaline phosphatase-conjugated anti-DIG antibody
(1:10,000, Roche) was added to a membrane. Signals were raised by
CDP-star (Roche) and detected by LAS3000 imaging system.
Short Tandem Repeat Analysis and Karyotyping
The genomic DNAwas used for PCRwith Powerplex 16 system (Prom-
ega) and analyzed by ABI PRISM 3100 Genetic analyzer and Gene.
Mapper v3.5 (Applied Biosystems). Chromosomal G-band analyses
were performed at the Nihon Gene Research Laboratories, Japan.
Detection of Telomerase Activity
Telomerase activity was detected with a TRAPEZE telomerase detec-
tion kit (Chemicon), according to the manufacturer’s instructions. The
samples were separated by TBE-based 10% acrylamide nondenatur-
ing gel electrophoresis. The gel was stainedwith SYBRGold (1:10,000,
Invitrogen).
Chromatin immunoprecuipitation Assay
Approximately 1 3 107 cells were crosslinked with 1% formaldehyde
for 5 min at room temperature and quenched by addition of glycine.
The cell lysate was sonicated to share chromatin-DNA complex.
Immunoprecipitation was performed with Dynabeads Protein G (Invi-
trogen) -linked anti-trimethyl Lys 4 histone H3 (07-473, Upstate),
anti-trimethyl Lys 27 histone H3 (07-449, Upstate) or normal rabbit
IgG antibody. Eluates were used for quantitative PCR as templates.
DNA Microarray
Total RNA from HDF and hiPS cells (clone 201B) was labeled with Cy3.
Samples were hybridized with Whole Human Genome Microarray 4 3
44K (G4112F, Agilent). Each sample was hybridized once with the one
color protocol. Arrays were scanned with a G2565BA Microarray
Scanner System (Agilent). Data analyzed by using GeneSpring
GX7.3.1 software (Agilent). Two normalization procedures were ap-
plied; first, signal intensities less than 0.01 were set to 0.01. Then
each chip was normalized to the 50th percentile of the measurements
taken from that chip. The microarray data of hES H9 cells (Tesar et al.,
2007) were retrieved from GEO DataSets (GSM194390, http://www.
ncbi.nlm.nih.gov/sites/entrez?db=gds&cmd=search&term=GSE7902).
Genes with ‘‘present’’ flag value in all three samples were used for
analyses (32,266 genes). We have deposited the microarray data of
HDF and hiPS cells to GEO DataSets with the accession number
GSE9561.
Supplemental Data
Supplemental Data include 6 figures, 12 tables, and 1 movie and can
be found with this article online at http://www.cell.com/cgi/content/
full/131/5/861/DC1/.
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